Not familiar with the drug at all , but based off of what you typed in that is a couple hail Marys. The FDA shut down our EIND, and doesn't care because einds are anecdotal. No placebo. If a big pharma was involved somehow it would have the slimmest of margin chances. An otc pink sheeter with barely anything except anecdotal evidence doesn't sound promising. More promotion fodder. I could be 100% completely wrong, but based on cydys treatment with actual valid evidence I think it's an educated opinion.